Clinical trial
Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients
NCT01764230 is registered in ClinicalTrials.gov with Masaryk University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients
- Lead sponsor
- Masaryk University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2004
- Completion date
- January 31, 2008
- Enrollment
- 72 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hodgkin disease, hodgkin lymphoma